Cargando…

Brolucizumab and immunogenicity

Detalles Bibliográficos
Autores principales:	Sharma, Ashish, Kumar, Nilesh, Parachuri, Nikulaa, Sharma, Rohini, Bandello, Francesco, Kuppermann, Baruch D., Loewenstein, Anat
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7608337/ https://www.ncbi.nlm.nih.gov/pubmed/32251366 http://dx.doi.org/10.1038/s41433-020-0853-9

Ejemplares similares

Brolucizumab—another anti-VEGF or beyond
por: Sharma, Ashish, et al.
Publicado: (2020)

Brolucizumab and fluid in neovascular age-related macular degeneration (n-AMD)
por: Sharma, Ashish, et al.
Publicado: (2020)

Smartphone based ROP (S-ROP) screening—opportunities and challenges
por: patil, Jayaprakash, et al.
Publicado: (2020)

Pachydrusen: the epidemiology of pachydrusen and its relevance to progression of pachychoroid disease spectrum
por: Sheth, Jay, et al.
Publicado: (2020)

Supplemental nutrition for retinal health: Evidence based analysis of commercial preparations in India
por: Sharma, Ashish, et al.
Publicado: (2022)

Port delivery system with ranibizumab (Susvimo) recall- What does it mean to the retina specialists
por: Sharma, Ashish, et al.
Publicado: (2023)

Ranizurel safety evaluation in real-world -(RaSER) study
por: Sharma, Ashish, et al.
Publicado: (2022)

Commentary: Acute central serous chorioretinopathy – Treat early, observe longer
por: Kumar, Nilesh, et al.
Publicado: (2021)

Ophthalmic biosimilars: Lessons from India
por: Sharma, Ashish, et al.
Publicado: (2019)

Correction: Comment on: ‘Recent advances in anterior chamber angle imaging’
por: Kumar, Nilesh, et al.
Publicado: (2020)

Comment on: ‘Recent advances in anterior chamber angle imaging’
por: Kumar, Nilesh, et al.
Publicado: (2020)

Biosimilars in ophthalmology: “Is there a big change on the horizon?”
por: Sharma, Ashish, et al.
Publicado: (2018)

Dexamethasone intravitreal implant in the treatment of diabetic macular edema
por: Dugel, Pravin U, et al.
Publicado: (2015)

Use of Intravitreal Triamcinolone in the Treatment of Macular Edema Related to Retinal Vein Occlusion
por: Sharma, Ashish, et al.
Publicado: (2008)

Immunogenic cell death and immunogenic surrender: related but distinct mechanisms of immune surveillance
por: Mezzapelle, Rosanna, et al.
Publicado: (2021)

Brolucizumab for macular degeneration
Publicado: (2020)

Side Effects of Brolucizumab
por: Motevasseli, Tahmineh, et al.
Publicado: (2021)

Efficacy and safety of brolucizumab versus aflibercept in eyes with early persistent retinal fluid: 96-week outcomes from the HAWK and HARRIER studies
por: Lally, David R., et al.
Publicado: (2022)

Taking the right measures to control COVID-19 in ophthalmology: the experience of a tertiary eye care referral center in Italy
por: Borrelli, Enrico, et al.
Publicado: (2020)

From choice architecture to choice engineering
por: Dan, Ohad, et al.
Publicado: (2019)

Correction: Efficacy and safety of brolucizumab versus aflibercept in eyes with early persistent retinal fluid: 96-week outcomes from the HAWK and HARRIER studies
por: Lally, David R., et al.
Publicado: (2022)

Valganciclovir in the treatment of cytomegalovirus retinitis in HIV-infected patients
por: Patil, A Jayaprakash, et al.
Publicado: (2010)

Erratum: Side Effects of Brolucizumab
Publicado: (2022)

Improving COVID-19 vaccine immunogenicity by interrupting methotrexate treatment
por: Sparks, Jeffrey A, et al.
Publicado: (2022)

The combination therapy of subtenon triamcinolone acetonide injection and intravitreal brolucizumab for brolucizumab-related intraocular inflammation
por: Shigemoto, Yumi, et al.
Publicado: (2021)

Dexamethasone intravitreal implant in previously treated patients with diabetic macular edema: subgroup analysis of the MEAD study
por: Augustin, Albert J., et al.
Publicado: (2015)

Comments on Immunogenicity Associated with Botulinum Toxin Treatment. Toxins 2019, 11, 491
por: Foster, Keith, et al.
Publicado: (2020)

Is This a 737 Max Moment for Brolucizumab?
por: Rosenfeld, Philip J., et al.
Publicado: (2020)

Natural immunity helps overcome the age-related decline of SARS-CoV-2 vaccine immunogenicity
por: Verschoor, Chris P, et al.
Publicado: (2022)

Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease
por: Haberman, Rebecca H, et al.
Publicado: (2022)

Immunogenicity and safety of BNT162b2 mRNA vaccine booster in actively treated patients with cancer
por: Ligumsky, Hagai, et al.
Publicado: (2022)

Heterologous ChAdOx1-nCoV19–BNT162b2 vaccination provides superior immunogenicity against COVID-19
por: Richardson, Christopher D
Publicado: (2021)

Comments on “Transcutaneous tibial nerve stimulation versus parasacral stimulation in the treatment of overactive bladder in elderly people: A triple-blinded randomized controlled trial”
por: Srivastav, Apoorva, et al.
Publicado: (2020)

Comment on: Is this a 737 Max Moment for Brolucizumab
por: Kayath, Marcia, et al.
Publicado: (2021)

Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours
por: Oosting, Sjoukje F, et al.
Publicado: (2022)

Strengthening malaria microscopy using artificial intelligence-based approaches in India
por: Nema, Shrikant, et al.
Publicado: (2022)

Fundamental principles of an effective diabetic retinopathy screening program
por: Lanzetta, Paolo, et al.
Publicado: (2020)

Correction to: Fundamental principles of an effective diabetic retinopathy screening program
por: Lanzetta, Paolo, et al.
Publicado: (2020)

Urgent actions and policies needed to address COVID-19 among UK ethnic minorities
por: Mathur, Rohini, et al.
Publicado: (2020)

Remarks on Sasidharan et al. “Evaluation of the Hepatoprotective Effects of Lantadene A, a Pentacyclic Triterpenoid of Lantana Plants against Acetaminophen-induced Liver Damage”. Molecules 2012, 17, 13937-13947
por: Sharma, Manu
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_onialasghd42ibjr037ask6dlb